论文信息 - Phase 2 study of cobimetinib in combination with vemurafenib in active melanoma brain metastases (coBRIM-B). - 字舞流文

Phase 2 study of cobimetinib in combination with vemurafenib in active melanoma brain metastases (coBRIM-B).

J. Kirkwood | H. Tawbi | L. Butterfield | H. Kluger | P. Chapman | A. Pavlick | L. Schuchter | M. Milhem | R. Amaravadi | Yan Lin | T. Gangadhar | A. Tarhini | V. Gorantla | M. Yee